{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:12:25Z","timestamp":1787807545915,"version":"build-2784847793"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.parkreldis.2021.03.018","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T20:39:11Z","timestamp":1617050351000},"page":"114-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Fatigue in hypokinetic, hyperkinetic, and functional movement disorders"],"prefix":"10.1016","volume":"86","author":[{"given":"Ilaria Antonella","family":"Di Vico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-8773","authenticated-orcid":false,"given":"Giovanni","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1740-8566","authenticated-orcid":false,"given":"Alessandro","family":"Tessitore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5246-2109","authenticated-orcid":false,"given":"Mattia","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Falup-Pecurariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3321-1125","authenticated-orcid":false,"given":"Gioacchino","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9834-3639","authenticated-orcid":false,"given":"Francesca","family":"Morgante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Tinazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.03.018_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/mds.26511","article-title":"Parkinson's disease-related fatigue: a case definition and recommendations for clinical research","volume":"31","author":"Kluger","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/bs.irn.2017.05.007","article-title":"Fatigue in Parkinson's disease","author":"Kluger","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1212\/WNL.0b013e31827f07be","article-title":"Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy","volume":"80","author":"Kluger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib4","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/mds.27461","article-title":"Fatigue in Parkinson's disease: a systematic review and meta-analysis","volume":"33","author":"Siciliano","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrneurol.2017.117","article-title":"Fatigue as a symptom or comorbidity of neurological diseases","volume":"13","author":"Penner","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00002512-200926030-00002","article-title":"Physical and mental fatigue in Parkinson\u02bcs disease","volume":"26","author":"Lou","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-510X(00)00411-1","article-title":"Fatigue and basal ganglia","volume":"179","author":"Chaudhuri","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib9","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/mds.22989","article-title":"Fatigue rating scales critique and recommendations by the Movement Disorders Society Task Force on rating scales for Parkinson's disease","volume":"25","author":"Friedman","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib11","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.parkreldis.2004.07.007","article-title":"The Parkinson fatigue scale","volume":"11","author":"Brown","year":"2005","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib13","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1038\/s41598-020-61076-1","article-title":"Fatigue profiles in patients with multiple sclerosis are based on severity of fatigue and not on dimensions of fatigue","volume":"10","author":"Beckerman","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib15","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0404.2003.02033.x","article-title":"The influence of fatigue on health-related quality of life in patients with Parkinson's disease","volume":"107","author":"Herlofson","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib17","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000055868.06222.AB","article-title":"Effects of fatigue on physical activity and function in patients with Parkinson's disease","author":"Garber","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in Parkinson's disease (the onset pd study)","volume":"30","author":"Pont-Sunyer","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.wnl.0000324862.29733.69","article-title":"Fatigue in levodopa-na\u00efve subjects with Parkinson disease","volume":"71","author":"Schifitto","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ncl.2012.08.018","article-title":"Psychiatric disorders and sleep","author":"Krystal","year":"2012","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib21","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/brain\/awx153","article-title":"The fatigue conundrum","volume":"140","author":"Kuppuswamy","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.clinph.2019.01.017","article-title":"Central fatigue and attentional processing in Parkinson's disease: an event-related potentials study","volume":"130","author":"Pauletti","year":"2019","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.parkreldis.2019.11.017","article-title":"Subjective memory decline in Parkinson's disease patients with and without fatigue","volume":"70","author":"Siciliano","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mds.21240","article-title":"Fatigue in Parkinson's disease: a review","volume":"22","author":"Friedman","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3988\/jcn.2016.12.2.172","article-title":"Parkinson's disease with fatigue: clinical characteristics and potential mechanisms relevant to \u03b1-synuclein oligomer","volume":"12","author":"Zuo","year":"2016","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib26","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-201919","article-title":"The dysfunctional autonomic function and \u201cdysfunctional\u201d fatigue in drug na\u00efve Parkinson's disease","author":"Ahn","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib27","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/mds.23744","article-title":"Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease?","volume":"26","author":"Nakamura","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib28","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s10072-018-3569-x","article-title":"Does fatigue in Parkinson's disease correlate with autonomic nervous system dysfunction?","volume":"39","author":"Olivola","year":"2018","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jns.2017.04.023","article-title":"Association between autonomic dysfunction and fatigue in Parkinson disease","volume":"377","author":"Chou","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.14802\/jmd.19066","article-title":"The non-motor symptom profile of progressive supranuclear palsy","volume":"13","author":"Chaithra","year":"2020","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00415-009-5255-7","article-title":"Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study","volume":"257","author":"Colosimo","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2013.01.034","article-title":"The interrelationship between non-motor symptoms in Atypical Parkinsonism","volume":"327","author":"Lee","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib33","article-title":"Non motor symptoms in progressive supranuclear palsy: prevalence and severity, Npj Park","volume":"3","author":"Radicati","year":"2017","journal-title":"Dis"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib34","first-page":"S55","article-title":"Non-motor symptoms in progressive supranuclear palsy","volume":"31","author":"Ou","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10286-019-00651-7","article-title":"Clinical features of multiple system atrophy with or without rapid eye movement behavior disorder: a cross-sectional study in southwest China","volume":"30","author":"Wang","year":"2020","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.parkreldis.2016.12.007","article-title":"Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes","volume":"35","author":"Zhang","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib37","article-title":"Characteristics of nonmotor symptoms in progressive supranuclear palsy","volume":"2016","author":"Ou","year":"2016","journal-title":"Parkinsons. Dis."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib38","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3109\/00207454.2015.1085035","article-title":"High rates of fatigue and sleep disturbances in dystonia","volume":"126","author":"Shukla","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.baga.2014.10.002","article-title":"Nonmotor symptoms and focal cervical dystonia: observations from 102 patients","volume":"4","author":"Klingelhoefer","year":"2014","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mdc3.12510","article-title":"The frequency and self-perceived impact on daily life of motor and non-motor symptoms in cervical dystonia","volume":"4","author":"Smit","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/mdc3.12459","article-title":"Fatigue, sleep disturbances, and their influence on quality of life in cervical dystonia patients","volume":"4","author":"Smit","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.015","article-title":"Myoclonus-dystonia: distinctive motor and non-motor phenotype from other dystonia syndromes","volume":"69","author":"Timmers","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2017.10.005","article-title":"Non-motor symptoms and quality of life in dopa-responsive dystonia patients","volume":"45","author":"Timmers","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0404.2011.01573.x","article-title":"Non-motor features in essential tremor","volume":"125","author":"Chandran","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s13760-014-0396-6","article-title":"Cognitive functions, fatigue, depression, anxiety, and sleep disturbances: assessment of nonmotor features in young patients with essential tremor","volume":"115","author":"Sengul","year":"2015","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib46","article-title":"Clinical profile of non-motor symptoms in patients with essential tremor: impact on quality of life and age-related differences","volume":"9","author":"Shalash","year":"2019","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y)."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-018-8915-7","article-title":"Fatigue, not self-rated motor symptom severity, affects quality of life in functional motor disorders","author":"Gelauff","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpsychores.2018.10.001","article-title":"The impact of non-motor symptoms on the health-related quality of life in patients with functional movement disorders","volume":"115","author":"V\u011bchetov\u00e1","year":"2018","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib49","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00415-014-7631-1","article-title":"Outcomes of a 5-day physiotherapy programme for functional (psychogenic) motor disorders","volume":"262","author":"Nielsen","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib50","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/jnnp-2016-314408","article-title":"Randomised feasibility study of physiotherapy for patients with functional motor symptoms","volume":"88","author":"Nielsen","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib51","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(04)15794-2","article-title":"Fatigue in neurological disorders","volume":"363","author":"Chaudhuri","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib52","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/mds.26650","article-title":"Functional connectivity underpinnings of fatigue in \u201cDrug-Na\u00efve\u201d patients with Parkinson's disease","volume":"31","author":"Tessitore","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib53","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00702-020-02219-6","article-title":"Supplementary motor area functional connectivity in \u201cdrug-na\u00efve\u201d Parkinson's disease patients with fatigue","volume":"127","author":"Siciliano","year":"2020","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib54","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/mds.10505","article-title":"Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo controlled, crossover study","volume":"18","author":"Lou","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib55","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1468-1331.2007.01858.x","article-title":"Lack of post-exercise depression of corticospinal excitability in patients with Parkinson's disease","volume":"14","author":"Khedr","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib56","article-title":"Interventions for fatigue in Parkinson's disease","volume":"2015","author":"Elbers","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2015.11.029","article-title":"Neuroimaging and clinical predictors of fatigue in Parkinson disease","volume":"23","author":"Chou","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib58","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/brain\/awq268","article-title":"Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction","volume":"133","author":"Pavese","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biopsych.2004.10.031","article-title":"Brain 5-HT 1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C] WAY-100635","volume":"57","author":"Cleare","year":"2005","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib60","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease","volume":"26","author":"McCoy","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","article-title":"Cerebrospinal fluid inflammatory markers in Parkinson's disease - associations with depression, fatigue, and cognitive impairment","volume":"33","author":"Lindqvist","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2016.09.030","article-title":"IL-6 serum levels are elevated in Parkinson's disease patients with fatigue compared to patients without fatigue","volume":"370","author":"Pereira","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib63","article-title":"Effort awareness and sense of volition in schizophrenia, Conscious","author":"Lafargue","year":"2009","journal-title":"Cogn"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1474-4422(11)70073-4","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes","volume":"10","author":"Rascol","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib65","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2169\/internalmedicine.50.5456","article-title":"Pramipexole reduces the prevalence of fatigue in patients with Parkinson's disease","volume":"50","author":"Morita","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib66","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jnnp.72.6.713","article-title":"Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study","volume":"72","author":"Pogarell","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib67","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1212\/WNL.49.3.724","article-title":"Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease","volume":"49","author":"Shannon","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib68","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/ene.12757","article-title":"Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial","volume":"22","author":"Antonini","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib69","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2016.5260","article-title":"Treatment of fatigue in Parkinson disease","volume":"315","author":"Elbers","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib70","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/mds.21656","article-title":"Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial","volume":"22","author":"Mendon\u00e7a","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.parkreldis.2016.03.002","article-title":"Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: systematic review and meta-analysis","volume":"27","author":"Rodrigues","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib72","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease - a randomized study","volume":"19","author":"Rios Romenets","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib73","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mds.26159","article-title":"Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)","volume":"30","author":"Pahwa","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib74","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/0269215511432652","article-title":"Home-based treadmill training for individuals with Parkinson's disease: a randomized controlled pilot trial","volume":"26","author":"Canning","year":"2012","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib75","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1152\/japplphysiol.01277.2013","article-title":"Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease","volume":"116","author":"Kelly","year":"2014","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib76","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.0000000000000644","article-title":"Phase I\/II randomized trial of aerobic exercise in Parkinson disease in a community setting","volume":"83","author":"Uc","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.03.018_bib77","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","article-title":"Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial","volume":"18","author":"van der Kolk","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.018_bib78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mds.23966","article-title":"Weekly exercise does not improve fatigue levels in Parkinson's disease","volume":"27","author":"Winward","year":"2012","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:22:34Z","timestamp":1761178954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":77,"alternative-id":["S1353802021001115"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.018","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatigue in hypokinetic, hyperkinetic, and functional movement disorders","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}